Molecular pathology of prostate cancer
Open Access
- 1 July 2005
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 58 (7), 673-684
- https://doi.org/10.1136/jcp.2002.003954
Abstract
The molecular pathology of prostate cancer is complex; not only are multiple genes involved in its pathogenesis, but additional environmental factors such as diet and inflammation are also involved. The exhaustive research into prostate cancer to date has demonstrated a complex interaction of multiple genes and environmental factors, some of which may be more important in individual prostate cancer cases. This is an exciting era, with the emergence of new investigative tools such as DNA microarray technology and the application of the field of proteomics to the study of human cancers. Knowledge of genetic changes underlying the initiation, development, and progression of prostate cancer is accumulating rapidly. With increasing knowledge, it may be possible to distinguish indolent from aggressive prostate tumours by molecular fingerprinting. This review discusses the most consistently reported molecular pathological findings in hereditary and sporadic prostate cancer, together with new concepts and technologies.Keywords
This publication has 141 references indexed in Scilit:
- Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological GradeCancer Research, 2004
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- Mutations in CHEK2 Associated with Prostate Cancer RiskAmerican Journal of Human Genetics, 2003
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ‐confined prostate cancerGenes, Chromosomes and Cancer, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancerOncogene, 1999
- Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary boneThe Prostate, 1996
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990